Tevogen Inc. (TVGN)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch TVGN
See up to 3 months of TVGN. The 7-day demo opens the 1M and 3M ranges and puts TVGN on your watchlist.
Start 7-day demoLatest TVGN insider trades
About Tevogen Inc. (TVGN)
The SEC lists Tevogen Inc. under CIK 0001860871, in biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
TVGN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 7 | 9,125,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
TVGN insider transactions (Form 4)
3027 Form 4 filings on record, the earliest from Oct 18, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Ryan H. Saadi - Officer | Grant or award | Common Stock | 8,000,000 footnote F1 | $0.00 | - | |
| ||||||
| Kirti Desai - Officer | Grant or award | Common Stock | 750,000 footnote F1 | $0.00 | - | |
| ||||||
| Keow Lin Goh - Director | Grant or award | Common Stock | 75,000 footnote F1 | $0.00 | - | |
| ||||||
| Susan M. Podlogar - Director | Grant or award | Common Stock | 75,000 footnote F1 | $0.00 | - | |
| ||||||
| Victor J. Sordillo - Director | Grant or award | Common Stock | 75,000 footnote F1 | $0.00 | - | |
| ||||||
| Jeffrey L. Feike - Director | Grant or award | Common Stock | 75,000 footnote F1 | $0.00 | - | |
| ||||||
| Curtis L. Patton - Director | Grant or award | Common Stock | 75,000 footnote F1 | $0.00 | - | |
| ||||||
| Victor J. Sordillo - Director | Grant or award | Common Stock | 40,000 footnote F1 | $0.00 | - | |
| ||||||
| Ryan H. Saadi - Officer | Grant or award | Common Stock | 1,220,000 footnote F1 | $0.00 | - | |
| ||||||
| Susan M. Podlogar - Director | Grant or award | Common Stock | 40,000 footnote F1 | $0.00 | - | |
| ||||||
| Curtis L. Patton - Director | Grant or award | Common Stock | 40,000 footnote F1 | $0.00 | - | |
| ||||||
| Keow Lin Goh - Director | Grant or award | Common Stock | 40,000 footnote F1 | $0.00 | - | |
| ||||||
| Jeffrey L. Feike - Director | Grant or award | Common Stock | 40,000 footnote F1 | $0.00 | - | |
| ||||||
| Kirti Desai - Officer | Grant or award | Common Stock | 40,000 footnote F1 | $0.00 | - | |
| ||||||
| Neal Flomenberg - Officer | Open-market sale | Common Stock | 19 | $7.75 | $147 | |
| Neal Flomenberg - Officer | Open-market sale | Common Stock | 452 | $7.26 footnote F2,F3 | $3K | |
| Neal Flomenberg - Officer | Open-market sale | Common Stock | 501 | $6.40 footnote F2,F4 | $3K | |
| ||||||
| Ryan H. Saadi - Officer | Gift | Common Stock | 50,000 | $0.00 | - | |
| Ryan H. Saadi - Officer | Gift | Common Stock | 20,000 | $0.00 | - | |
| Ryan H. Saadi - Officer | Grant or award | Common Stock | 8,000,000 | $0.00 | - | |
| Sadiq Khan - Officer | Grant or award | Common Stock | 200,000 | $0.00 | - | |
| Neal Flomenberg - Officer | Grant or award | Common Stock | 300,000 | $0.00 | - | |
| Kirti Desai - Officer | Grant or award | Common Stock | 750,000 | $0.00 | - | |
| Jeffrey L. Feike - Director | Grant or award | Common Stock | 240,000 | $0.00 | - | |
| Curtis L. Patton - Director | Grant or award | Common Stock | 240,000 | $0.00 | - | |
| Victor J. Sordillo - Director | Grant or award | Common Stock | 240,000 | $0.00 | - | |
| Victor J. Sordillo - Director | Grant or award | Common Stock | 240,000 | $0.00 | - | |
| Keow Lin Goh - Director | Grant or award | Common Stock | 240,000 | $0.00 | - | |
| Susan M. Podlogar - Director | Grant or award | Common Stock | 240,000 | $0.00 | - | |
| Neal Flomenberg - Officer | Open-market sale | Common Stock | 1,078,600 | $1.62 | $1.75M | |
Item 8.01, 9.01
Item 5.02, 9.01
Item 8.01
Item 5.02, 5.03, 5.07, 9.01
TVGN insider trading FAQ
What is the latest insider trade for TVGN?
Tevogen Inc. (TVGN) had 7 insider filings in the last 90 days, with the most recent on 2026-09-16. The full record for TVGN runs to 27 Form 4 filings, the earliest from 2024-10-18. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TVGN stock?
No insider purchases of TVGN were filed in the last 90 days.
How many insiders are selling TVGN stock?
No insider sales of TVGN were filed in the last 90 days. 4 sales are on record for this company.
Where can I see TVGN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TVGN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Ryan H. Saadi view on EDGAR
- - Kirti Desai view on EDGAR
- - Keow Lin Goh view on EDGAR
- - Susan M. Podlogar view on EDGAR
- - Victor J. Sordillo view on EDGAR
- - Jeffrey L. Feike view on EDGAR
- - Curtis L. Patton view on EDGAR
- - Victor J. Sordillo view on EDGAR
- - Ryan H. Saadi view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where TVGN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TVGN with a 7-day demo
- TVGN on your watchlist
- Every TVGN Form 4 filing on record
- Up to 3 months of TVGN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
